Neuromics is partnering with Javeen Biosciences to bring you Cancer Stem Cells and Hepatocytes derived from donor Induced Pluripotent Stem Cells.
Rodney Nash, Javeen CEO, and his team are working to fill a major gap in cell-based drug discoveries. The lack of cells from specific diseased or ethnic populations. This limits the ability to predict how well a drug candidate will work with a diverse population of patients.
Dr. Rodney Nash, CEO, Javeen BiosciencesOver time, we envision Javeen Biosciences as having the ability to engineer cells from donors that match tightly with the needs of drug hunters.
We ask you to "Think of 8". This video illustrates the power Javeen Biosciences' solutions
Much more to follow...